De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Bicycle Therapeutics Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Bicycle Therapeutics heeft een totaal eigen vermogen van $873.8M en een totale schuld van $30.9M, wat de schuld-eigenvermogensverhouding op 3.5% brengt. De totale activa en totale passiva bedragen respectievelijk $1.1B en $183.5M.
Belangrijke informatie
3.5%
Verhouding schuld/eigen vermogen
US$30.91m
Schuld
Rente dekkingsratio | n/a |
Contant | US$961.36m |
Aandelen | US$873.81m |
Totaal verplichtingen | US$183.54m |
Totaal activa | US$1.06b |
Recente financiële gezondheidsupdates
Does Bicycle Therapeutics (NASDAQ:BCYC) Have A Healthy Balance Sheet?
Apr 19Bicycle Therapeutics (NASDAQ:BCYC) Is Using Debt Safely
Jan 04Is Bicycle Therapeutics (NASDAQ:BCYC) Using Debt In A Risky Way?
Mar 09Is Bicycle Therapeutics (NASDAQ:BCYC) Weighed On By Its Debt Load?
Jul 10Is Bicycle Therapeutics (NASDAQ:BCYC) A Risky Investment?
Apr 11Bicycle Therapeutics (NASDAQ:BCYC) Has Debt But No Earnings; Should You Worry?
Nov 07Recent updates
Bicycle Therapeutics Is Looking Increasingly Attractive
Aug 20Bicycle Therapeutics Boosts Balance Sheet To Navigate Data Desert
May 24Shareholders May Not Be So Generous With Bicycle Therapeutics plc's (NASDAQ:BCYC) CEO Compensation And Here's Why
May 10Analysts' Revenue Estimates For Bicycle Therapeutics plc (NASDAQ:BCYC) Are Surging Higher
May 04Does Bicycle Therapeutics (NASDAQ:BCYC) Have A Healthy Balance Sheet?
Apr 19Bicycle: 2nd Half Of 2024 Data Could Provide Significant Inflection Point
Mar 12Bicycle Therapeutics (NASDAQ:BCYC) Is Using Debt Safely
Jan 04Newsflash: Bicycle Therapeutics plc (NASDAQ:BCYC) Analysts Have Been Trimming Their Revenue Forecasts
Nov 07The Bicycle Therapeutics plc (NASDAQ:BCYC) Analysts Have Been Trimming Their Sales Forecasts
May 14Industry Analysts Just Upgraded Their Bicycle Therapeutics plc (NASDAQ:BCYC) Revenue Forecasts By 26%
Mar 31Is Bicycle Therapeutics (NASDAQ:BCYC) Using Debt In A Risky Way?
Mar 09Time To Worry? Analysts Just Downgraded Their Bicycle Therapeutics plc (NASDAQ:BCYC) Outlook
Nov 08Bicycle Therapeutics: Exploring An Intriguing Developmental Platform
Oct 08Bicycle Therapeutics initiated Outperform at Cowen citing drug platform
Aug 31Bicycle to get $10M as Genentech uses option for new program under cancer drug collaboration
Jul 12Is Bicycle Therapeutics (NASDAQ:BCYC) Weighed On By Its Debt Load?
Jul 10Bicycle Therapeutics: Promising Early-Stage Cancer Drug Developer
Jul 05Bicycle Therapeutics: Trying To Catch This Falling Knife
Apr 17Is Bicycle Therapeutics (NASDAQ:BCYC) A Risky Investment?
Apr 11Bicycle Therapeutics: A Buy Ahead Of AACR Presentation
Mar 25Bicycle Therapeutics: An Oncology Play With Big Potential
Feb 28Bicycle Therapeutics (NASDAQ:BCYC) Has Debt But No Earnings; Should You Worry?
Nov 07Bicycle Therapeutics: Scaffolding Short Linear Peptides Into Bicycles
Aug 25The Consensus EPS Estimates For Bicycle Therapeutics plc (NASDAQ:BCYC) Just Fell Dramatically
Aug 07News Flash: Analysts Just Made A Sizeable Upgrade To Their Bicycle Therapeutics plc (NASDAQ:BCYC) Forecasts
May 08Bicycle Therapeutics EPS misses by $0.05, beats on revenue
May 06Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $1.0B ) BCYC } overtreffen de korte termijn passiva ( $69.6M ).
Langlopende schulden: De kortetermijnactiva BCYC ( $1.0B ) overtreffen de langetermijnschulden ( $113.9M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: BCYC heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van BCYC is de afgelopen 5 jaar gestegen van 0% naar 3.5%.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: BCYC heeft op basis van de huidige vrije kasstroom voldoende cash runway voor meer dan 3 jaar.
Voorspelling contante baan: Er zijn onvoldoende gegevens om te bepalen of BCYC voldoende cash runway heeft als de vrije kasstroom blijft groeien of krimpen op basis van historische percentages.